No Data
No Data
BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
Express News | BioRestorative Therapies Announced That Its Chief Scientist And Vice President Of Research And Development, Francisco Silva, Will Present At The Annual International Federation For Adipose Therapeutics And Science Conference
BioRestorative Therapies' IFATS 2024 Presentation to Feature ThermoStem Platform's Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs
Maxim Group Maintains Biorestorative Therapies(BRTX.US) With Buy Rating, Maintains Target Price $6
Buy Rating Affirmed for BioRestorative Therapies Amid Strong Financials and Clinical Progress
Express News | Roth MKM Maintains Buy on BioRestorative Therapies, Raises Price Target to $18
No Data
No Data